Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast...

Future Oncology 2017 / 12 Vol. 13; Iss. 30

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, Alessandra, Giannarelli, Diana, Moscetti, Luca, Santini, Daniele, Zambelli, Alberto, Laurentiis, Michelino De, Caruso, Michele, Generali, Daniele, Valle, Enrichetta, Leonardi, Vita, Cannita, Kat
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2017-0336
Date:
December, 2017
File:
PDF, 631 KB
english, 2017
Conversion to is in progress
Conversion to is failed